FindTrial
Sign In

A retrospective study of clinical drug therapy in patients with novel coronavirus pneumonia (COVID-19)

A retrospective study of clinical drug therapy in patients with COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030802
Enrollment
Unknown
Registered
2020-03-15
Start date
2020-01-27
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

Tongji Hospital, Tongji medical college of HUST
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnosis of COVID-19; 2. In-patients admitted in designated hospitals.

Exclusion criteria

Exclusion criteria: 1. Incomplete medical records, especially medication information,which may affect the evaluation 2. Those which the researchers deemed inappropriate

Design outcomes

Primary

MeasureTime frame
time and rate of cure; proportion and time of patients who progressed to severe disease;—

Secondary

MeasureTime frame
Remission rate of pneumonia symptoms;—

Countries

China

Contacts

Public ContactLIU DONG

Tongji Hospital, Tongji Medical College of HUST

ld_2069@163.com+86 13507183749

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026